Allspring Global Investments
AZN icon

Allspring Global Investments’s AstraZeneca AZN Stock Holding History

Allspring Global Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$151M Sell
818,235
-10,134
-1% -$1.91M 0.23% 100
2026
Q1 		$166M Buy
828,369
+13,983
+2% +$2.7M 0.28% 88
2025
Q4 		$149M Buy
814,386
+718,627
+750% +$126M 0.24% 108
2025
Q3 		$16.2M Buy
95,759
+8,774
+10% +$1.33M 0.03% 583
2025
Q2 		$12.4M Sell
86,985
-1,933
-2% -$271K 0.02% 640
2025
Q1 		$12.9M Buy
88,918
+12,070
+16% +$1.75M 0.02% 638
2024
Q4 		$10.1M Buy
76,848
+46,536
+154% +$6.52M 0.02% 755
2024
Q3 		$4.72M Buy
30,312
+22,094
+269% +$3.57M 0.01% 959
2024
Q2 		$1.28M Buy
8,218
+2,970
+57% +$447K ﹤0.01% 1280
2024
Q1 		$711K Buy
5,248
+3,325
+173% +$440K ﹤0.01% 1444
2023
Q4 		$259K Hold
1,923
– – ﹤0.01% 1642
2023
Q3 		$260K Buy
1,923
+180
+10% +$24.6K ﹤0.01% 1689
2023
Q2 		$249K Hold
1,743
– – ﹤0.01% 1741
2023
Q1 		$242K Hold
1,743
– – ﹤0.01% 1772
2022
Q4 		$236K Sell
1,743
-7,791
-82% -$977K ﹤0.01% 1790
2022
Q3 		$1.04M Hold
9,534
– – ﹤0.01% 1419
2022
Q2 		$1.26M Sell
9,534
-158
-2% -$20.7K ﹤0.01% 1372
2022
Q1 		$1.28M Buy
9,692
+8,011
+477% +$961K ﹤0.01% 1740
2021
Q4 		$195K Buy
+1,681
New +$198K ﹤0.01% 2640

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Allspring Global Investments's AZN Position: Q2 2026 in Review

Allspring Global Investments reduced its AstraZeneca (AZN) stake by 1.2% in Q2 2026, selling an estimated $1.91M and leaving 818,235 shares worth $151M. The position accounts for 0.23% of the portfolio, ranked #100.

Allspring Global Investments first reported a position in AZN in Q4 2021 and has held it in 19 quarters since. The position peaked at $166M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Allspring Global Investments held 818,235 shares of AstraZeneca worth $151M as of Q2 2026.
  • Allspring Global Investments sold 10,134 AstraZeneca shares in Q2 2026, an estimated $1.91M.
  • AstraZeneca made up 0.23% of Allspring Global Investments's portfolio in Q2 2026, its #100 holding.
  • Allspring Global Investments first reported a position in AstraZeneca in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's AstraZeneca position peaked at $166M in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.